Researchers identified a promising approach to slowing treatment-resistant prostate cancer by targeting two key cancer pathways at the same time. Prostate cancer is diagnosed in about one in eight men during their lifetime. Many survive the disease, but for some, it eventually spreads beyond the prostate and becomes metastatic. In the United States, prostate cancer […]